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ABSTRACT
Objective: To evaluate the efficacy and tolerability of lysine cream in patients with second-degree superficial burns.
Methods: In this randomized, open label, comparative study patients with second degree superficial burns received either combination of lysine 
cream 15% and silver sulfadiazine cream 1% or sulfadiazine cream 1% alone,  twice daily for period of 4 weeks. The primary outcome, pain, discharge, 
size and total body surface area (TBSA) were assessed in each visits.
Results: Patients in the study group showed significant change than the control group in pain, discharge, size, and TBSA during the first 4 weeks after 
treatment. In addition, significantly more patients in lysine group had adequate relief of itching and increased epithelialization.
Conclusions: Combination of lysine cream and silver sulfadiazine cream for 4 weeks provided significant relief of pain, discharge, size, TBSA, and 
itching. Lysine cream was well tolerated.
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INTRODUCTION
Burns are injuries to the skin or other tissues, caused by heat, radiation, 
chemicals, or electrical contact. Burn injuries are among the most 
devastating of all injuries and a major global public health crisis [1].
During the healing process, the body requires increased amount 
of proteins. Administration of high protein to burns patients 
improves nutritional status and immunological response. Dietary 
supplementation with pharmacological levels of specific amino acid 
and fatty acid, either alone or in combination, may improve the clinical 
course of critically ill burns patients [2].
L-lysine is an essential amino acid in that it is required for human nutrition 
but not produced by the body. Lysine has been shown to remarkably 
improve both the rate and quality of wound healing with less scarring 
and deformation. Wounds which are treated topically with lysine show 
a controlled degree of inflammation and angiogenesis process, whereby, 
probably, required extent of cellular and serum growth factors entry into 
the wound beds are ensured, thereby augmenting the healing process 
in situ. Lysine-mediated angiogenesis is postulated to be a result of the 
molecule acting as cell surface bridge, binding the angiogenic factors to 
their receptors. This augments the angiogenesis induced by lysine molecule 
by means of the ligand-receptor binding process. Thus, L-lysine has been 
shown to promote therapeutic angiogenesis in wound healing [3,4]. Hence, 
this study has been undertaken to find out the efficacy of topical L-lysine 
cream in second-degree superficial burns in terms of wound healing and 
also to compare the same with silver sulfadiazine cream, which is used in 
the hospital as part of the standard treatment schedule.
METHODS
A randomized, open-label, comparative, prospective, parallel group 
study was conducted on patients with second-degree superficial burns 
(only limbs) <10% involvement, attending the outpatient Department 
of Burns, Plastic and Reconstructive Surgery, Kilpauk Medical College 
and Hospital and outpatient Department of Plastic Surgery, Rajiv 
Gandhi Government General Hospital Chennai, Tamil Nadu, between 
August 2010 and June 2011. The study duration for each patient was 
4 weeks with four visits. The study was commenced after obtaining 
approval from the Institutional Ethical Committee.
Inclusion criteria
•	 Hemodynamically	stable and age ranges between 20 and 50 years 
of both sex
•	 Second-degree	superficial	burns	(only	limbs)	with	<10%	of	the	total	









Patients were randomized to enter any of the two groups: Silver 
sulfadiazine therapy (Group A) and combination therapy comprising of 
both silver sulfadiazine and lysine (Group B). Each group consisted of 
20 patients.
Parameters assessed
The size, degree, pain, discharge, and TBSA were assessed in each visit.
RESULTS
In this study, 125 patients were screened, of which 40 patients, who 
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were enrolled, completed the study, and there were no dropouts. The 
following clinical parameters were assessed in all patients during each 
visit:
•	 The	size	of	the	burns	wound	was	measured	with	a	ruler,	taking	the	








The data was tabulated in Microsoft Excel and analyzed using SPSS 
version	16.	The	comparison	between	test	and	control	group	in	each	
category (prevalence of pain, wound discharge, size of burns, TBSA 
of burns) at each visit was done using an independent t-test. The 
level of significance was set to p<0.05 (where p is the probability 
value).
OBSERVATION
The following parameters are tabulated (Table 1-7).
DISCUSSION
Second-degree superficial burns heal by themselves even though 
infection is the most frequent and life-threatening complication in 
patients with burns. The three efficacious and most extensively used 
topical antimicrobial agents available for the treatment of second-
degree superficial burns are silver sulfadiazine cream, mafenide acetate 
cream, and 0.5% silver nitrate soaks [5]. However, no single agent is 
totally effective and has its own advantages and disadvantages.
Among the three topical agents, silver sulfadiazine is most favored agent 
because of its high patient compliance, excellent spectrum of activity, low 
toxicity, easy application, and also it does not impede epithelialization.
A large number of molecules are being tested for the promotion of 
therapeutic angiogenesis including vascular endothelial growth factor. 
L-lysine monohydrochloride (L-lysine) has been shown to promote 
therapeutic angiogenesis in wound healing [3,4]. Pre-clinical studies 
done by Siméon et al.	 and	Fromes	et al. in the wound healing showed 
that lysine when given with other amino acids (naturally occurring 
copper complex of a glycyl-L-histidyl-L-lysine peptide and acetyl-serine- 
aspartyl- lysine-proline) as a topical agent hastened wound healing 
process. The topical application of L-lysine monohydrochloride 15% 
with silver sulfadiazine 1% increases the healing rate by promoting rapid 
epithelialization of second-degree superficial burns. Lysine has been 
shown to improve both the rate and the quality of wound healing with 
less scarring. This study was undertaken to evaluate the efficacy of lysine 
cream	in	second-degree	superficial	burns.	Our	study	is	the	first	of	its	kind	
using lysine cream in the treatment of second-degree superficial burns. 
In this study, 40 patients were enrolled and divided into two groups. 
One	group	received	silver	sulfadiazine	cream,	and	other	group	received	
lysine in addition to silver sulfadiazine cream for 4 weeks. The following 
parameters were evaluated - size, pain, discharge, and TBSA of burns.
There was no statistically significant difference between the groups in 
mean age. This shows that both groups belong to the same population 
(p=0.173). The distribution of sex in both groups did not show any 
statistically	significant	difference	(p=0.744).	Our	study	showed	that	in	
Group B, there was a significant reduction in the size of the burn wound 
and also TBSA of the burns.
The mean size of the wound at the end of the study was 108.00 cm2 in 
Group	B,	while	in	Group	A,	it	was	176.45	cm2. Similarly, mean TBSA of 
Table 1: Mean age
Study groups n Age in years (mean±SD) Student 
independent
t‑test
Group A 20 31.400±6.660 p=0.173NS
Group B 20 28.550±6.328
SD: Standard deviation, NS: Non-significant
Table 2: Distribution of sex




t‑testGroup A Group B
Male 12	(60.0) 13	(65.0) 0.107 p=0.744 (NS)
Female 8 (40.0) 7 (35.0)
Total 20 (100) 20 (100)
Table 3: Prevalence of pain
Visits Group A Group B Chi‑square value Student independent t‑test
Present Absent Present Absent
1 20 0 20 0 0.000 p=1.000 (NS)
2 20 0 19 1 1.026 p=0.311 (NS)
3 15 5 8 12 5.013 p=0.025 (S)
4 1 19 0 20 1.026 p=0.311 (NS)
5 0 20 0 20 0.000 p=1.000 (NS)
Friedman	test p<0.001 (S) p<0.001 (S)
S: Significant, NS: Non-significant
Table 4: Wound discharge
Visits Group A Group B Chi‑square value Student independent t‑test
Present Absent Present Absent
1 20 0 20 0 0.000 p=1.000 (NS)
2 20 0 10 10 13.333 p<0.000 (S)
3 3 17 0 20 3.243 p=0.072 (NS)
4 0 20 0 20 0.000 p=1.000 (NS)
5 0 20 0 20 0.000 p=1.000 (NS)
Friedman	test p<0.001 (S) p<0.001 (S)
S: Significant, NS: Non-significant
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the burns in Group B was 1.23%, whereas in Group A was 1.80%. The 
reduction in size and TBSA of burns in the lysine-treated group were 
noticed from the 2nd week onward when compared to the standard 
silver sulfadiazine-treated group. This shows that the study drug lysine 
which was used along with silver sulfadiazine is probably responsible 
for this reduction in both the size and TBSA of burns.
Similarly, there was a reduction in the discharge in Group B from the 
2nd week onward, and no discharge was observed from the 3rd week. 
This again points out that the lysine in the combination group (Group B) 
probably contributes to the faster healing seen in this group.
Pain reduction was statistically significant in both the groups. In the 
lysine combination group, the pain reduction was observed from the 
2nd week itself, whereas in the other group, it was observed only from 
the 3rd week. This also suggests that lysine has contributed to the pain 
reduction and has hastened the healing process.
The rate of healing of wound in the lysine combination group (Group B) 
was	 69%	 when	 compared	 to	 the	 silver	 sulfadiazine-treated	 group	
(Group A) which was only 42%. This probably can be attributed to the 
angiogenic property of lysine.
The angiogenic property of lysine was demonstrated in a study, where 
the effects of L-lysine monohydrochloride on ischemia reversibility 
were studied. L-lysine was administered intravenously at a dose of 
60	mg/kg	in	patients	with	symptoms	of	acute	hemispheric	stroke.	All	
11 patients treated with lysine showed marked recovery in terms of 
significant changes in relative cerebral blood flow, relative cerebral 
blood volume, and mean transit time ratios. This observation suggests 
that functional recovery in these 11 patients was probably due to 
lysine-induced angiogenesis in the ischemic	tissue	[6].
Another	study	conducted	by	Faculty	of	Medicine	at	France	with	glycyl-	
L-histidyl-L-lysine showed that L-lysine significantly promoted wound 
healing [7] which is in accordance with this study. A small study 
conducted in our department in Grade 1 and 2 diabetic ulcers also 
showed that lysine promoted ulcer healing which also supports the 
wound healing property of L-lysine.
No adverse events were reported during the study period, which 
suggests that topical lysine was well tolerated. The biochemical 
parameters such as blood sugar, urea, serum creatinine, and electrolytes 
did not show any statistically significant difference between the groups, 
suggesting that lysine does not have any systemic effects.
As there was a definite reduction in size, discharge, pain, and TBSA of 
burns in second-degree superficial burns, our study conducted in the 
tertiary care hospital proves that L-lysine in combination with silver 
sulfadiazine has promoted faster healing of burn wound than silver 
sulfadiazine alone.
CONCLUSION
From	 this	 study,	 we	 can	 conclude	 that	 lysine	 cream	 is	 effective	 in	
promoting the healing of second-degree superficial burns and also 
well tolerated. Among patients who had second-degree superficial 
burns, treatment with lysine cream for 4 weeks provided significant 
improvement in pain, discharge, size, TBSA, and itching.
The rate of healing of wound in the lysine combination group was better 
because of the angiogenic property of lysine. In addition, significantly 
more patients in lysine group had adequate relief of itching and 
increased epithelialization.
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Table 5: Size of burns
Visits Mean±SD Student 
independent 
t‑testGroup A Group B
1 303.30±233.240 343.50±191.565 p=0.555 (NS)
2 297.65±230.932 303.50±169.393 p=0.928	(NS)
3 242.25±201.002 228.10±143.990 p=0.799	(NS)
4 215.25±187.466 161.85±110.978 p=0.280 (NS)
5 176.45±163.448 108.00±89.022 p=0.108 (NS)
Friedman	
test
p<0.001 (S) p<0.001 (S)
S: Significant, NS: Non-significant, SD: Standard deviation
Table 6: TBSA of burns
Visits Mean±SD Student 
independent t‑testGroup A Group B
1 2.950±1.3659 3.050±1.5720 p=0.831 (NS)
2 2.925±1.3599 2.295±1.4892 p=1.000 (NS)
3 2.475±1.3026 2.350±1.3774 p=0.770 (NS)
4 2.250±1.1754 1.775±1.1639 p=0.207 (NS)
5 1.800±1.1286 1.225±0.8955 p=0.082 (NS)
Friedman	
test
p<0.001 (S) p<0.001 (S)
TBSA: Total body surface area, S: Significant, NS: Non-significant, SD: Standard 
deviation
Table 7: Rate of healing (%)
Groups Size of the ulcer, mean (%) Rate of healing (%)
Baseline visit Last visit
Group A 303.30 (100) 176.45	(58) 42
Group B 343.50 (100) 108.00 (31) 69
